Low-dose aspirin confers a survival benefit in patients with pathological advanced-stage oral squamous cell carcinoma

Low-dose aspirin confers a survival benefit in patients with pathological advanced-stage oral squamous cell carcinoma

Abstract Oral squamous cell carcinoma (OSCC) remains one of the most challenging clinical problems in the field due to its high rate of locoregional and distant metastases. However, studies that assess the association between aspirin use and survival in patients with OSCC are limited. Moreover, pati...

Full description

Bibliographic Details
Main Authors: Sheng-Dean Luo, Shao-Chun Wu, Wei-Chih Chen, Ching-Nung Wu, Tai-Jan Chiu, Yao-Hsu Yang, Shau-Hsuan Li, Fu-Min Fang, Tai-Lin Huang, Chang-Chun Hsiao, Chang-Han Chen
Format: Article
Language:English
Published: Nature Publishing Group 2021-08-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-021-96614-y

Internet

https://doi.org/10.1038/s41598-021-96614-y

Similar Items